Budget impact of tepotinib in the treatment of adult patients with metastatic non-small cell lung cancer harboring METex14 skipping alterations in the United States-Reference-Cited by-同舟云学术

Budget impact of tepotinib in the treatment of adult patients with metastatic non-small cell lung cancer harboring METex14 skipping alterations in the United States

Published:2021-01-01 Issue:1 Volume:24 Page:816-827
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Stargardter Matthew¹,McBride Ali²^ORCID,Tosh Jon³^ORCID,Sachdev Rameet¹,Yang Mo⁴,Ambavane Apoorva¹,Mittal Madhav¹,Vioix Helene⁵,Liu Frank Xiaoqing⁴

Affiliation:

1. Evidera, Evidence Synthesis, Modeling, & Communication, Bethesda, MD, USA

2. The University of Arizona College of Pharmacy – Tucson, Tucson, AZ, USA

3. Evidera, Evidence Synthesis, Modeling, & Communication, London, UK

4. EMD Serono, Rockland, MA, USA

5. Merck KGaA, Darmstadt, Germany

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2021.1942017

Reference43 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

3. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

4. SEER. National Cancer Institute – surveillance, epidemiology, and end results – cancer stat facts: lung and bronchus cancer; 2020; [cited 2020 May 4]. Available from: https://seer.cancer.gov/statfacts/html/lungb.html

5. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Budget impact models for lung cancer interventions: A systematic literature review;Journal of Managed Care & Specialty Pharmacy;2024-09

2. The Health Inequality Impact of Liquid Biopsy to Inform First-Line Treatment of Advanced Non–Small Cell Lung Cancer: A Distributional Cost-Effectiveness Analysis;Value in Health;2023-12

3. Cost-Effectiveness of Tepotinib Versus Capmatinib for the Treatment of Adult Patients With Metastatic Non–Small Cell Lung Cancer Harboring Mesenchymal–Epithelial Transition Exon 14 Skipping;Value in Health;2023-04

4. Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices;Current Oncology;2023-02-15

5. The budget impact of introducing mobocertinib for the postplatinum treatment of advanced non–small cell lung cancer harboring epidermal growth factor receptor exon 20 insertion mutations;Journal of Managed Care & Specialty Pharmacy;2023-02